Clinical evaluation of the cobas® MTB-RIF/INH reagent and the cobas® 6800 for the detection of isoniazid and rifampicin resistance

World Health Organization, 2020 World Health Organization, 2020 Global laboratory initiative, 2018 Arentz, 2013, Systematic review of the performance of rapid rifampicin resistance testing for drug-resistant tuberculosis, PLoS One, 8, 10.1371/journal.pone.0076533 European Centre for Disease Prevention and Control, 2018 Tuberculosis Research Committee RYOKEN, 2015, Nationwide survey of anti-tuberculosis drug resistance in Japan, Int J Tubercul Lung Dis, 19, 157, 10.5588/ijtld.13.0905 Tuberculosis Research Committee RYOKEN, 2019, Nationwide survey of anti-tuberculosis drug resistance in Japan: 2012–2013, Kekkaku, 94, 439 Kohl, 2018, MTBseq: a comprehensive pipeline for whole genome sequence analysis of Mycobacterium tuberculosis complex isolates, PeerJ, 6, 10.7717/peerj.5895 2021 Van Deun, 2013, Rifampin drug resistance tests for tuberculosis: challenging the gold standard, J Clin Microbiol, 51, 2633, 10.1128/JCM.00553-13 Miotto, 2018, Role of disputed mutations in the rpoB gene in interpretation of automated liquid MGIT culture results for rfampin susceptibility testing of Mycobacterium tuberculosis, J Clin Microbiol, 56, 10.1128/JCM.01599-17 World Health Organization, 2018 Banfi, 2003, Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility, J Antimicrob Chemother, 52, 796, 10.1093/jac/dkg439 Perdigão, 2020, Using Genomics to understand the origin and dispersion of multidrug and extensively drug resistant tuberculosis in Portugal, Sci Rep, 10, 2600, 10.1038/s41598-020-59558-3 Mitarai, 2007, Comparative study of BACTEC MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid, Kekkaku, 82, 891 Abe, 2008, Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan, J Clin Microbiol, 46, 2263, 10.1128/JCM.00561-08 Chikamatsu, 2011, Evaluation of GenoType MTBDRplus for the detection of multi-drug resistant Mycobacterium tuberculosis strains, Kekkaku, 86, 697 Igarashi, 2017, Laboratory evaluation of AnyplexTM II MTB/MDR and MTB/XDR based on multiplex real-time PCR and melting-temperature analysis for identifying Mycobacterium tuberculosis and drug resistance, Diagn Microbiol Infect Dis, 89, 276, 10.1016/j.diagmicrobio.2017.08.016 Blakemore, 2010, Evaluation of the analytical performance of the Xpert MTB/RIF assay, J Clin Microbiol, 48, 2495, 10.1128/JCM.00128-10 Rinder, 2001, Heteroresistance in Mycobacterium tuberculosis, Int J Tubercul Lung Dis, 5, 339 Kawatsu, 2016, Profile of tuberculosis among the foreign-born population in Japan, 2007-2014, Western Pac Surveill Response J, 7, 7, 10.5365/wpsar.2016.7.1.008 World Health Organization, 2014 World Health Organization, 2013 World Health Organization, 2017 World Health Organization, 2020 Ling, 2008, GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis, Eur Respir J, 32, 1165, 10.1183/09031936.00061808